THE MAMMOGRAPHY CENTER OF MONTEREY INSTALLS FUJIFILM’S DIGITAL BREAST TOMOSYNTHESIS SYSTEM
Stamford, CT, July 31, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, today announced that The Mammography Center of Monterey, an ACR-accredited breast imaging center based in Monterey, CA, has installed Fujifilm’s ASPIRE Cristalle FFDM system with Digital Breast Tomosynthesis (DBT). The innovative 3D breast imaging technology has been in use at the center since April.
“We are pleased and excited that The Mammography Center has selected Fujifilm’s ASPIRE Cristalle with DBT. It is especially gratifying to know that women in the Monterey area have access to advanced technology such as breast tomosynthesis in their own community,” said Rob Fabrizio, Director of Strategic Marketing, Digital Radiography and Women’s Health, FUJIFILM Medical Systems U.S.A., Inc. “We look forward to continuing to support The Mammography Center of Monterey in their efforts to educate women and build awareness about the benefits of 3D mammography with both clinicians and patients.”
In business for 28 years, The Mammography Center of Monterey was seeking to expand its offerings with the latest mammography technology. The facility decided to make an investment in the latest advanced technology versus staying with a traditional 2D system. After evaluating competitive breast tomosynthesis units—and speaking with both a technologist and a radiologist familiar with the ASPIRE Cristalle—the facility opted for Fujifilm’s ASPIRE Cristalle.
“Radiologists at the center are impressed with the technology and their ability to clearly see details, especially in images of dense breast tissue,” said Mary Lou Catania, RN, Founder and President, The Mammography Center of Monterey.
According to Catania, since the center began using ASPIRE Cristalle with DBT, recall rates have dropped and in fact, there have been no patients recalled due to dense breast images.
Catania also stated that the Fujifilm system is easy-to-use, comfortable for patients, and affordable. She credits the company with a smooth installation and excellent training, saying technologists quickly got up to speed on the ASPIRE Cristalle and were able to rapidly get back on track performing a backlog of patient exams.
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow to optimize patient dose while maximizing image quality.
For more information about Fujifilm, please visit www.fujimed.com.
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit healthcaresolutions-us.fujifilm.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2016, the company had global revenues of $22.1 billion, at an exchange rate of 112.54 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.